Corteva, Inc. $CTVA Stake Lifted by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise lifted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 305.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,311 shares of the company’s stock after acquiring an additional 13,797 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Corteva were worth $1,533,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new position in Corteva during the third quarter valued at about $25,000. Garton & Associates Financial Advisors LLC acquired a new stake in Corteva in the 4th quarter valued at about $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva in the 4th quarter valued at about $28,000. Cornerstone Financial Management LLC bought a new position in shares of Corteva during the 4th quarter valued at about $29,000. Finally, Basepoint Wealth LLC acquired a new position in shares of Corteva in the 4th quarter worth approximately $30,000. Institutional investors own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CTVA. Deutsche Bank Aktiengesellschaft increased their price objective on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Mizuho lifted their target price on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Royal Bank Of Canada upped their target price on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Finally, Berenberg Bank lifted their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $88.81.

Corteva Stock Performance

CTVA stock opened at $82.60 on Friday. The company has a 50 day moving average price of $79.38 and a 200 day moving average price of $76.20. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock has a market capitalization of $55.24 billion, a PE ratio of 48.59, a price-to-earnings-growth ratio of 2.50 and a beta of 0.57.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period last year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s payout ratio is 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.